Characteristica | Intervention | Control | Inter-action | ||||||
---|---|---|---|---|---|---|---|---|---|
Baseline | Follow-up | OR (95% CI)** | p-value** | Baseline | Follow-up | OR (95% CI)** | p-value** | p-value** | |
Women | |||||||||
CVD patients | |||||||||
Statin prescribed | 39.1 (382/978) | 54.6 (574/1051) | 1.86 (1.56–2.22) | < 0.001 | 24.3 (78/321) | 33.0 (107/324) | 1.53 (1.08–2.16) | 0.016 | 0.314 |
HT drug prescribed | 90.3 (883/978) | 93.1 (978/1051) | 1.43 (1.04–1.96) | 0.029 | 81.0 (260/321) | 86.1 (279/324) | 1.43 (0.94–2.19) | 0.096 | 0.959 |
TC documented | 33.5 (328/978) | 60.2 (633/1051) | 3.07 (2.56–3.69) | < 0.001 | 24.3 (78/321) | 28.1 (91/324) | 1.25 (0.87–1.78) | 0.224 | < 0.001 |
TC at normal range | 30.5 (100/328) | 34.4 (218/633) | 1.20 (0.90–1.60) | 0.215 | 29.5 (23/78) | 48.4 (44/91) | 2.18 (1.15–4.15) | 0.017 | 0.078 |
HT patients | |||||||||
HT drug prescribed | 93.5 (1030/1102) | 96.0 (1127/1174) | 1.67 (1.15–2.44) | 0.008 | 85.2 (339/398) | 89.7 (366/408) | 1.46 (0.95–2.23) | 0.084 | 0.710 |
BP control | 15.2 (134/882) | 12.1 (120/995) | 0.77 (0.59–1.01) | 0.055 | 10.4 (33/316) | 13.2 (46/348) | 1.32 (0.82–2.12) | 0.255 | 0.054 |
DM patients | |||||||||
HbA1c documented | 21.4 (49/229) | 27.1 (71/262) | 1.44 (0.95–2.20) | 0.089 | 9.3 (5/54) | 10.7 (9/84) | 1.15 (0.36–3.65) | 0.817 | 0.720 |
FG documented | 91.7 (210/229) | 92.4 (242/262) | 1.16 (0.60–2.25) | 0.656 | 77.8 (42/54) | 89.3 (75/84) | 2.37 (0.92–6.12) | 0.076 | 0.231 |
TC documented | 41.9 (96/229) | 64.1 (168/262) | 2.48 (1.72–3.57) | < 0.001 | 29.6 (16/54) | 34.5 (29/84) | 1.24 (0.59–2.60) | 0.563 | 0.101 |
Statin prescribed | 49.8 (114/229) | 59.2 (155/262) | 1.45 (1.01–2.08) | 0.043 | 24.1 (13/54) | 32.1 (27/84) | 1.52 (0.70–3.31) | 0.291 | 0.924 |
BP control | 2.7 (6/226) | 4.7 (12/258) | 1.89 (0.70–5.14) | 0.212 | 9.8 (5/51) | 6.0 (5/84) | 0.58 (0.16–2.12) | 0.412 | 0.168 |
FG control | 35.2 (74/210) | 40.5 (98/242) | 1.20 (0.82–1.77) | 0.352 | 47.6 (20/42) | 44.0 (33/75) | 0.89 (0.41–1.90) | 0.755 | 0.484 |
TC at normal range | 29.2 (28/96) | 30.4 (51/168) | 1.01 (0.58–1.76) | 0.979 | 12.5 (2/16) | 37.9 (11/29) | 4.36 (0.82–23.21) | 0.085 | 0.089 |
Men | |||||||||
CVD patients | |||||||||
Statin prescribed | 47.9 (395/825) | 56.3 (502/891) | 1.39 (1.15–1.69) | 0.001 | 30.7 (79/257) | 43.0 (120/279) | 1.66 (1.16–2.37) | 0.006 | 0.390 |
HT drug prescribed | 87.0 (718/825) | 90.1 (803/891) | 1.36 (1.01–1.83) | 0.046 | 76.3 (196/257) | 84.9 (237/279) | 1.68 (1.08–2.61) | 0.020 | 0.364 |
TC documented | 35.8 (295/825) | 60.8 (542/891) | 2.85 (2.34–3.47) | < 0.001 | 25.2 (65/257) | 33.7 (94/279) | 1.65 (1.12–2.42) | 0.011 | 0.006 |
TC at normal range | 41.0 (121/295) | 43.9 (238/542) | 1.12 (0.84–1.50) | 0.435 | 49.2 (32/65) | 50.0 (47/94) | 1.01 (0.54–1.91) | 0.969 | 0.793 |
HT patients | |||||||||
HT drug prescribed | 91.6 (846/924) | 94.5 (924/978) | 1.56 (1.09–2.24) | 0.015 | 82.9 (271/327) | 89.2 (313/351) | 1.58 (1.01–2.47) | 0.046 | 0.863 |
BP control | 14.8 (104/705) | 15.6 (126/806) | 1.08 (0.82–1.44) | 0.578 | 9.6 (24/250) | 13.8 (42/305) | 1.53 (0.89–2.60) | 0.122 | 0.254 |
DM patients | |||||||||
HbA1c documented | 21.2 (33/156) | 27.1 (52/192) | 1.40 (0.84–2.31) | 0.194 | 9.8 (5/51) | 15.9 (11/69) | 2.13 (0.67–6.80) | 0.203 | 0.565 |
FG documented | 83.3 (130/156) | 91.1 (175/192) | 2.06 (1.07–3.95) | 0.030 | 86.3 (44/51) | 79.7 (55/69) | 0.65 (0.24–1.78) | 0.402 | 0.055 |
TC documented | 46.2 (72/156) | 70.3 (135/192) | 2.78 (1.78–4.32) | < 0.001 | 49.0 (25/51) | 42.0 (29/69) | 0.82 (0.39–1.73) | 0.607 | 0.004 |
Statin prescribed | 57.7 (90/156) | 62.5 (120/192) | 1.22 (0.79–1.89) | 0.361 | 31.4 (16/51) | 43.5 (30/69) | 1.62 (0.75–3.48) | 0.222 | 0.578 |
BP control | 6.5 (10/153) | 7.8 (15/192) | 1.22 (0.53–2.80) | 0.647 | 2.1 (1/47) | 6.0 (4/67) | 3.36 (0.35–32.02) | 0.292 | 0.521 |
FG control | 38.5 (50/130) | 38.9 (68/175) | 1.02 (0.64–1.64) | 0.925 | 47.7 (21/44) | 40.0 (22/55) | 0.76 (0.34–1.69) | 0.496 | 0.425 |
TC at normal range | 41.7 (30/72) | 34.1 (46/135) | 0.72 (0.40–1.31) | 0.283 | 36.0 (9/25) | 27.6 (8/29) | 0.62 (0.19–2.00) | 0.420 | 0.873 |